Joshua Dennerlein
Stock Analyst at B of A Securities
(2.24)
# 2,545
Out of 4,832 analysts
91
Total ratings
45.16%
Success rate
-4.51%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SUI Sun Communities | Maintains: Underperform | $124 → $132 | $118.12 | +11.75% | 3 | May 12, 2025 | |
MSCI MSCI Inc. | Initiates: Neutral | $585 | $565.95 | +3.37% | 1 | Apr 10, 2025 | |
WELL Welltower | Maintains: Buy | $221 → $242 | $143.46 | +68.69% | 7 | Feb 18, 2025 | |
FVR FrontView REIT | Initiates: Buy | $22 | $11.79 | +86.60% | 1 | Oct 28, 2024 | |
GTY Getty Realty | Upgrades: Buy | $31 → $34 | $27.92 | +21.78% | 3 | Oct 21, 2024 | |
AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $34.15 | -9.22% | 2 | Sep 24, 2024 | |
NHI National Health Investors | Initiates: Buy | $92 | $73.47 | +25.22% | 1 | Sep 24, 2024 | |
ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $278.43 | +15.29% | 3 | Sep 24, 2024 | |
LINE Lineage | Initiates: Buy | $100 | $45.93 | +117.72% | 1 | Aug 19, 2024 | |
CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $115.90 | +26.83% | 4 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $158.45 | +19.28% | 3 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $52.13 | -23.27% | 4 | May 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $17.00 | +47.06% | 2 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $35.86 | -13.54% | 11 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $63.96 | -17.14% | 9 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $6.17 | -2.76% | 1 | Nov 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $41.20 | -19.90% | 1 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $15.38 | -2.47% | 2 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $54.65 | -4.85% | 1 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $17.57 | - | 4 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $60.17 | -10.25% | 4 | Sep 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.91 | +63.10% | 9 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $12.08 | +123.60% | 1 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $17.69 | +89.37% | 5 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.26 | - | 4 | Aug 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $72.44 | +7.68% | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $40.60 | +15.76% | 2 | Jan 20, 2022 |
Sun Communities
May 12, 2025
Maintains: Underperform
Price Target: $124 → $132
Current: $118.12
Upside: +11.75%
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $565.95
Upside: +3.37%
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $143.46
Upside: +68.69%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $11.79
Upside: +86.60%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $27.92
Upside: +21.78%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $34.15
Upside: -9.22%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $73.47
Upside: +25.22%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $278.43
Upside: +15.29%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $45.93
Upside: +117.72%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $115.90
Upside: +26.83%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $158.45
Upside: +19.28%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $52.13
Upside: -23.27%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $17.00
Upside: +47.06%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $35.86
Upside: -13.54%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $63.96
Upside: -17.14%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $6.17
Upside: -2.76%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $41.20
Upside: -19.90%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $15.38
Upside: -2.47%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $54.65
Upside: -4.85%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $17.57
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $60.17
Upside: -10.25%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.91
Upside: +63.10%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $12.08
Upside: +123.60%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $17.69
Upside: +89.37%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.26
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $72.44
Upside: +7.68%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $40.60
Upside: +15.76%